Merck KGaA
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more
Merck KGaA (MRK) - Total Assets
Latest total assets as of September 2025: €50.93 Billion EUR
Based on the latest financial reports, Merck KGaA (MRK) holds total assets worth €50.93 Billion EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Merck KGaA - Total Assets Trend (2002–2024)
This chart illustrates how Merck KGaA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Merck KGaA - Asset Composition Analysis
Current Asset Composition (December 2024)
Merck KGaA's total assets of €50.93 Billion consist of 26.1% current assets and 73.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.2% |
| Accounts Receivable | €4.08 Billion | 7.9% |
| Inventory | €4.48 Billion | 8.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.28 Billion | 12.2% |
| Goodwill | €19.15 Billion | 37.1% |
Asset Composition Trend (2002–2024)
This chart illustrates how Merck KGaA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Merck KGaA's current assets represent 26.1% of total assets in 2024, a decrease from 41.9% in 2002.
- Cash Position: Cash and equivalents constituted 4.2% of total assets in 2024, down from 4.5% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 24.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 37.1% of total assets.
Merck KGaA Competitors by Total Assets
Key competitors of Merck KGaA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Merck KGaA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Merck KGaA generates 0.41x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Merck KGaA generates $5.39 in net profit.
Merck KGaA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.49 | 1.33 | 1.01 |
| Quick Ratio | 0.97 | 0.91 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €4.24 Billion | € 3.47 Billion | € 49.00 Million |
Merck KGaA - Advanced Valuation Insights
This section examines the relationship between Merck KGaA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.92 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | 6.3% |
| Total Assets | €51.57 Billion |
| Market Capitalization | $14.54 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Merck KGaA's assets below their book value (0.28 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Merck KGaA's assets grew by 6.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Merck KGaA (2002–2024)
The table below shows the annual total assets of Merck KGaA from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €51.57 Billion | +6.33% |
| 2023-12-31 | €48.49 Billion | -0.06% |
| 2022-12-31 | €48.53 Billion | +6.98% |
| 2021-12-31 | €45.36 Billion | +8.53% |
| 2020-12-31 | €41.80 Billion | -4.60% |
| 2019-12-31 | €43.81 Billion | +18.77% |
| 2018-12-31 | €36.89 Billion | +3.56% |
| 2017-12-31 | €35.62 Billion | -6.88% |
| 2016-12-31 | €38.25 Billion | +0.64% |
| 2015-12-31 | €38.01 Billion | +46.12% |
| 2014-12-31 | €26.01 Billion | +24.94% |
| 2013-12-31 | €20.82 Billion | -3.81% |
| 2012-12-31 | €21.64 Billion | -2.16% |
| 2011-12-31 | €22.12 Billion | -1.20% |
| 2010-12-31 | €22.39 Billion | +33.96% |
| 2009-12-31 | €16.71 Billion | +6.83% |
| 2008-12-31 | €15.64 Billion | +4.84% |
| 2007-12-31 | €14.92 Billion | +84.17% |
| 2006-12-31 | €8.10 Billion | +11.29% |
| 2005-12-31 | €7.28 Billion | +27.24% |
| 2004-12-31 | €5.72 Billion | -18.05% |
| 2003-12-31 | €6.98 Billion | -7.04% |
| 2002-12-31 | €7.51 Billion | -- |